| Q34379694 | 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus |
| Q73695326 | A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients |
| Q36815937 | Age: an important factor in Barrett's oesophagus |
| Q34408960 | Alkaline gastro-oesophageal reflux: dual probe pH monitoring |
| Q72387566 | Barrett's esophagus |
| Q34353530 | Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management |
| Q42107603 | Benign oesophageal stricture in Barrett's columnar epithelialised oesophagus and its responsiveness to conservative management |
| Q36814501 | Bile reflux in columnar-lined Barrett's oesophagus |
| Q41601260 | Bile reflux in columnar-lined esophagus |
| Q41380542 | Carcinoma of the oesophagus: the time for a multidiciplinary approach? |
| Q73176619 | Characteristics of acid reflux in Barrett's esophagus |
| Q34408890 | Chemoprevention of esophageal adenocarcinoma |
| Q46332937 | Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin |
| Q44050401 | Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases |
| Q34392826 | Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus |
| Q42519506 | Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls |
| Q86344776 | Gastro-oesophageal reflux disease |
| Q40541121 | Gastroesophageal reflux: the use of pH monitoring |
| Q35623966 | How should Barrett's ulceration be treated? |
| Q51625297 | Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus |
| Q33757524 | Influence of Life Style Factors on Barrett's Oesophagus |
| Q34376173 | Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis |
| Q74646479 | Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation |
| Q41482831 | Management of refractory and complicated reflux esophagitis. |
| Q27025882 | Management of the patient with incomplete response to PPI therapy |
| Q35589387 | Medical management of Barrett's esophagus |
| Q41601246 | Motility abnormalities in the columnar-lined esophagus |
| Q35597874 | Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux |
| Q40595569 | Optimizing acid suppression for treatment of acid-related diseases |
| Q50524288 | Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. |
| Q33698844 | Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods |
| Q35350847 | Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? |
| Q34569452 | Standard antireflux operations in patients who have Barrett's esophagus. Current results. |
| Q33533940 | Surveillance of Barrett's esophagus in children |
| Q36816036 | Symptoms and endoscopic findings--can they predict abnormal nocturnal acid gastro-oesophageal reflux? |
| Q73913252 | The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion |
| Q34376917 | The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus |
| Q39453356 | The surgical management of Barrett's esophagus |
| Q78008248 | [Barrett's esophagus: the biological reality of a premaligmant columnar metaplasia] |